Anti-Factor VIII A2 domain (BOIIB2)

Anti-Factor VIII A2 domain [BOIIB2], Recombinant, IgG1 kappa, Human
Artikelnummer
ABAAb03957-10.0
Verpackungseinheit
100 μg
Hersteller
Absolute Antibody

Verfügbarkeit: wird geladen...
Preis wird geladen...
CloneID: BOIIB2

Antigen Long Description: The original antibody was generated from the peripheral blood lymphocytes obtained from a hemophilia patient.

Buffer Composition: PBS with 0.02% Proclin 300.

Available Custom Conjugation Options: AP, HRP, Fluorescein, APC, PE, Biotin Type A, Biotin Type B, Streptavidin, FluoroProbes 647H, Atto488, APC/Cy7, PE/Cy7

Uniprot Accession No.: P00451

Specificity Statement: This antibody binds the A2 domain of the human factor VIII, a glycoprotein involved in blood coagulation. Factor VIII acts as a cofactor for factor IXa which converts factor X to the activated form Xa in the presence of calcium and phospholipids. Defects in the F8 gene, which encodes Factor VIII, result in the coagulation disorder hemophilia A.

Application Notes (Clone): The binding specificity and epitope characterization of this antibody was determined using ELISA. The ability of this antibody inhibit factor VIII function in vitro was studied using a chromogenic functional assay. It was reported that this antibody inhibited the conversion of factor X to factor Xa at concentration of 0.1 μg/ml. It was found that this antibody inhibits thrombin production using both the intrinsic and extrinsic pathway of coagulation (US20080206254).
Mehr Informationen
Artikelnummer ABAAb03957-10.0
Hersteller Absolute Antibody
Hersteller Artikelnummer Ab03957-10.0
Verpackungseinheit 100 μg
Mengeneinheit STK
Reaktivität Human
Klonalität Recombinant
Methode ELISA
Isotyp IgG1 kappa
Wirt Human
Produktinformation (PDF) Download
MSDS (PDF) Download